1. Home
  2. JNVR vs SBFM Comparison

JNVR vs SBFM Comparison

Compare JNVR & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JNVR
  • SBFM
  • Stock Information
  • Founded
  • JNVR 2018
  • SBFM 2006
  • Country
  • JNVR United States
  • SBFM Canada
  • Employees
  • JNVR N/A
  • SBFM N/A
  • Industry
  • JNVR Finance: Consumer Services
  • SBFM Biotechnology: Pharmaceutical Preparations
  • Sector
  • JNVR Finance
  • SBFM Health Care
  • Exchange
  • JNVR Nasdaq
  • SBFM Nasdaq
  • Market Cap
  • JNVR 8.9M
  • SBFM 6.3M
  • IPO Year
  • JNVR 2023
  • SBFM N/A
  • Fundamental
  • Price
  • JNVR $0.76
  • SBFM $0.29
  • Analyst Decision
  • JNVR
  • SBFM Strong Buy
  • Analyst Count
  • JNVR 0
  • SBFM 1
  • Target Price
  • JNVR N/A
  • SBFM $260.00
  • AVG Volume (30 Days)
  • JNVR 1.0M
  • SBFM 1.5M
  • Earning Date
  • JNVR 07-30-2024
  • SBFM 08-08-2024
  • Dividend Yield
  • JNVR N/A
  • SBFM N/A
  • EPS Growth
  • JNVR N/A
  • SBFM N/A
  • EPS
  • JNVR N/A
  • SBFM N/A
  • Revenue
  • JNVR $1,947,052.00
  • SBFM $26,739,780.00
  • Revenue This Year
  • JNVR N/A
  • SBFM $87.97
  • Revenue Next Year
  • JNVR N/A
  • SBFM $125.23
  • P/E Ratio
  • JNVR N/A
  • SBFM N/A
  • Revenue Growth
  • JNVR N/A
  • SBFM 193.30
  • 52 Week Low
  • JNVR $0.70
  • SBFM $0.28
  • 52 Week High
  • JNVR $5.50
  • SBFM $64.50
  • Technical
  • Relative Strength Index (RSI)
  • JNVR 40.68
  • SBFM 32.97
  • Support Level
  • JNVR $0.72
  • SBFM $0.33
  • Resistance Level
  • JNVR $0.80
  • SBFM $0.35
  • Average True Range (ATR)
  • JNVR 0.09
  • SBFM 0.04
  • MACD
  • JNVR 0.00
  • SBFM 0.03
  • Stochastic Oscillator
  • JNVR 12.47
  • SBFM 4.54

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

Share on Social Networks: